Research programme: M1 muscarinic receptor modulators - Merck and Co.
Latest Information Update: 16 Jul 2016
Price : $50
At a glance
- Originator Merck & Co
- Class Carboxylic acids; Naphthalenes; Piperidines; Quinolizines; Quinolones
- Mechanism of Action Muscarinic M1 receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in USA (PO)
- 26 Aug 2010 Preclinical trials in Alzheimer's disease in USA (PO)